Medicine

BORIS: A. baumanni Highly Resistant β-Lactamase and Varying Susceptibility Patterns

Jennifer Lavrrar, Jane Hata, Jeanette Block
Jennifer Lavrrar, Jane Hata, Jeanette Block

REFERENCE: Slide Session C2-1360, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
JANE HATA, bioMéríeux Inc, Durham
Reports from the BORIS study call for ongoing surveillance of multi-drug resistant Acinetobacter Baumanii. Investigators found varying susceptibility and resistance patterns across the United States that highlight the organisms ability to adapt. Nicola Solomon spoke with Jane Hata of bioMéríeux.

Similar Interviews

  • Once-And-For-All TB Assay Brings Cheap, Sensitive, Specific, Seven-Day Diagnosis and Drug-Susceptibility Testing
  • DAVID MOORE, Imperial College, London and Lima REFERENCE: N Engl J Med 355: 1539-50 A new test for TB, trialled in Peru,

  • London School of Hygiene & Tropical Medicine Audio News Review, August 25th, 2007
  • David Moore Seven-Day Low-Cost Tuberculosis Diagnosis REFERENCE: N Engl J Med 355: 1539-50 DAVID MOORE,

  • Pharmacokinetically Enhanced Amoxicillin and Clavulanate for Drug Resistant Streptococcus Pneumoniae
  • Thomas File Thomas File, Summa Health System, Akron, Ohio Community Associated Pneumonia is a sizeable problem for health systems, and what is

    Post a comment

    Subscribe to Audio Medica Podcast